Bone, Exercise, Alendronate, and Caloric Restriction
The purpose of this research is to identify strategies that minimize bone loss that occurs when older adults lose weight. Participation in this research will involve up to nine assessment visits and l...
A Trial Evaluating Efficacy of AGA2118 in PostMenopausal Women wIth Low Bone MasS (ARTEMIS)
The primary objective of this study is to determine the effect of treatment with AGA2118 versus placebo at Month 12 on lumbar spine bone mineral density (BMD) in postmenopausal women with low bone mas...
Top Cities for Osteoporosis Clinical Trials
Osteoporosis clinical trials are recruiting across 11 cities. Here are the cities with the most active studies:
About Osteoporosis
Osteoporosis is a condition that weakens bones, making them fragile and more likely to break. It affects millions of people, particularly postmenopausal women. Treatment includes bisphosphonates, denosumab, calcium/vitamin D supplementation, and anabolic bone agents.
Clinical trials are advancing new treatments for osteoporosis. Currently, 2 studies are recruiting a combined 1,250 participants across the United States. Research is being conducted by 2 organizations including Wake Forest University Health Sciences, Angitia Biopharmaceuticals.
2026 Osteoporosis Research Landscape
As of March 2026, the osteoporosis clinical trial landscape includes 2 actively recruiting studies across 11 cities in the United States. These studies are collectively seeking 1,250 participants, with an average enrollment target of 625 per study.
Research is being led by 2 different organizations, including Wake Forest University Health Sciences, Angitia Biopharmaceuticals.
Geographically, osteoporosis trials are most concentrated in Buenos Aires, Argentina (2 trials); Aurora, Colorado (1 trial); Winston, Salem-North Carolina (1 trial); Birmingham, Alabama (1 trial); Tucson, Arizona (1 trial) and 6 other cities.
Featured Osteoporosis Studies
Highlighted recruiting studies for osteoporosis, selected by enrollment size and research scope.
Bone, Exercise, Alendronate, and Caloric Restriction
The purpose of this research is to identify strategies that minimize bone loss that occurs when older adults lose weight. Participation in this research will involve up to nine assessment visits and last up to two years.
A Trial Evaluating Efficacy of AGA2118 in PostMenopausal Women wIth Low Bone MasS (ARTEMIS)
The primary objective of this study is to determine the effect of treatment with AGA2118 versus placebo at Month 12 on lumbar spine bone mineral density (BMD) in postmenopausal women with low bone mass.
Frequently Asked Questions About Osteoporosis Clinical Trials
Are there osteoporosis clinical trials near me?
Yes, there are 2 osteoporosis clinical trials currently recruiting across 11+ cities in the United States, including Buenos Aires, Argentina; Aurora, Colorado; Winston, Salem-North Carolina. Browse the studies above to find one at a location convenient for you.
How do I join a osteoporosis clinical trial?
To join a osteoporosis clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are osteoporosis clinical trials free?
Yes, participation in osteoporosis clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of osteoporosis treatments are being studied?
Current osteoporosis clinical trials are testing a range of approaches. These include new drugs, combination therapies, medical devices, and other interventions sponsored by 2 research organizations.
Is it safe to participate in osteoporosis clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated March 2, 2026 from ClinicalTrials.gov
About This Data
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated March 2, 2026 · Data from ClinicalTrials.gov